NIH study showed no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms
On Aug. 18, 2021, the final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)…
On Aug. 18, 2021, the final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)…
On Aug. 17, 2021, researchers reported the delta variant of the virus that causes COVID-19 was not particularly…
On Aug. 16, 2021, scientists at the National Institutes of Health (NIH) announced they had developed a new…
On Aug. 16, 2021, Moderna announced a revised supply agreement with the Government of Canada for up to…
On Aug. 16, 2021, Pfizer and BioNTech announced that they have submitted Phase 1 data to the U.S….
On Aug. 13, 2021, Rigel Pharma announced that the U.S. Food and Drug Administration (FDA) had informed the…
On Aug. 13, 2021, Moderna announced that the Food and Drug Administration (FDA) had approved an update to…
On Aug. 12, 2021, Innovation Pharma released information regarding the status of its randomized, double-blind, placebo-controlled Phase 2…
On Aug. 12, 2021, the U.S. Department of Veterans Affairs (VA) announced that it expanded his previous COVID-19…
On Aug. 11, 2021, the World Health Organization (WHO) announced the next phase in its Solidarity trial that…
On Aug. 10, 2021, the National Institutes of Health (NIH) announced that a pilot study had begun to…
On Aug. 10, 2021, Cardinal Health announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19…
On Aug. 9, 2021, the Therapeutic Goods Administration (TGA), part of the Department of Health, granted provisional approval…
On Aug. 9, 2021, Inovio Pharma announced that it had received regulatory allowance for two clinical trials investigating…
On Aug. 6, 2021, the Centers for Disease Control and Prevention (CDC) announced in MMWR that a study…
On Aug. 5, 2021, Novavax announced preliminary data demonstrating that a single booster dose of its recombinant nanoparticle…
On Aug. 4, 2021, Novavax announced that it had reached an agreement with the European Commission (EC) for…
On Aug. 4, 2021, Regeneron announced that the New England Journal of Medicine (NEJM) had published positive detailed…
On Aug. 4, 2021, Inovio Pharma announced that the company had dosed the first Phase 2 trial subject…
On Aug. 3, 2021, Vanda Pharmaceuticals announced that enrollment had closed in the ODYSSEY study comparing tradipitant and…
On Aug. 3, 2021, CytoDyn announced that Brazil’s regulatory authority ANVISA (Agência Nacional de Vigilância Sanitária) has approved…
On Aug. 3, 2021, Illumina announced it had donated US $1 million in sequencing capabilities to the Molecular…
On Aug. 3, 2021, Eli Lilly and Incyte announced results from an additional cohort of 101 adult patients…
On Jul. 30, 2021, the Medicines Patent Pool and the World Health Organization, Afrigen Biologics, the Biologicals and…
On Jul. 30, 2021, Regeneron announced that the U.S. Food and Drug Administration (FDA) had updated the Emergency…
On Jul. 29, 2021, Incyte announced the U.S. Food and Drug Administration (FDA) had broadened the Emergency Use…
On Jul. 29, 2021, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had begun allowing…
On Jul. 29, 2021, Vaxart announced that it has shown for the first time in clinical trials that…
On Jul. 29, 2021, Cocrystal Pharma announced that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed…
On Jul. 29, 2021, the University of Oxford’s and AstraZeneca announced that one billion doses of the ChAdOx1…